Trusted Sources

FENOFIBRATE Questions ? Need a second opinion? Ask Our Health Experts!

Type your question here

 letters left

FENOFIBRATE Safety Reports

Total FENOFIBRATE reports: 194. FENOFIBRATE FDA safety alerts: No. Reported deaths: 17    Reported hospitalizations: 148. Read More Here.

< Previous  Showing 101-150 of 194 Next >

Consumer or non-health professional from FRANCE reported FENOFIBRATE problem on Mar 13, 2003. Male patient was diagnosed with dyslipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: pericarditis. FENOFIBRATE dosage: unknown. During the same period patient was treated with METFORMIN, INSULIN LISPRO, ACTOS, SERTRALINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

FENOFIBRATE problem was reported by a Consumer or non-health professional from FRANCE on July 23, 2002. Male patient was diagnosed with dyslipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: pneumothorax. FENOFIBRATE dosage: unknown. During the same period patient was treated with ALLOPURINOL, INDAPAMIDE, METFORMIN, ASPIRIN, TERAZOSIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from FRANCE reported FENOFIBRATE problem on Feb 22, 2002. Male patient was diagnosed with dyslipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: muscle strain, myalgia, neck pain. FENOFIBRATE dosage: unknown. During the same period patient was treated with GLUCOPHAGE, MIXTARD, MIXTARD, CILAZAPRIL. Patient was hospitalized. Patient recovered.

FENOFIBRATE problem was reported by a Consumer or non-health professional from FRANCE on Sept 16, 2002. Male patient was diagnosed with dyslipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: myocardial infarction, shock. FENOFIBRATE dosage: unknown. During the same period patient was treated with ALLOPURINOL, AMLODIPINE BESYLATE, GLUCOPHAGE, KARVEA HCT. Patient died on 07/15/2001.

Consumer or non-health professional from FRANCE reported FENOFIBRATE problem on Sept 30, 2004. Male patient was diagnosed with dyslipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: osteoporotic fracture. FENOFIBRATE dosage: unknown. During the same period patient was treated with PANCREATIN, DOXEPIN HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE, ALENDRONATE, GLIMEPIRIDE, QUININE SULPHATE. Patient was hospitalized. Patient recovered.

FENOFIBRATE problem was reported by a Consumer or non-health professional from FRANCE on Aug 11, 2003. Male patient was diagnosed with dyslipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: cyst, tendon rupture. FENOFIBRATE dosage: unknown. During the same period patient was treated with METFORMIN HYDROCHLORIDE, INSULIN ISOPHANE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from FRANCE reported FENOFIBRATE problem on Jan 20, 2003. Male patient was diagnosed with dyslipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: bradycardia, circulatory collapse. FENOFIBRATE dosage: unknown. During the same period patient was treated with ASPIRIN, GLYCERYL TRINITRATE, ISOSORBIDE, TERAZOSIN HYDROCHLORIDE, ATENOLOL. Patient was hospitalized. Patient recovered.

FENOFIBRATE problem was reported by a Consumer or non-health professional from FRANCE on June 18, 2003. Male patient was diagnosed with dyslipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: atrioventricular block. FENOFIBRATE dosage: unknown. During the same period patient was treated with MAGNESIUM, METFORMIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from FRANCE reported FENOFIBRATE problem on Sept 11, 2002. Female patient was diagnosed with dyslipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: tendon rupture. FENOFIBRATE dosage: unknown. During the same period patient was treated with ESTRIOL, NIMESULIDE, RAMIPRIL, HYDROCHLOROTHIAZIDE, BECLOMETHASONE DIPROPIONATE. Patient was hospitalized. Patient recovered.

FENOFIBRATE problem was reported by a Consumer or non-health professional from FRANCE on Jan 03, 2002. Male patient was diagnosed with dyslipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: labyrinthitis, vestibular disorder. FENOFIBRATE dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from FRANCE reported FENOFIBRATE problem on Oct 02, 2003. Female patient was diagnosed with dyslipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: hypoaesthesia, sensory loss. FENOFIBRATE dosage: unknown. During the same period patient was treated with ASPIRIN, CALCIUM CARBONATE, PIZOTIFEN MALEATE, BENDROFLUMETHIAZIDE, KAPSOVIT, ACETAMINOPHEN W, IBUPROFEN, AMITRIPTYLINE. Patient was hospitalized. Patient recovered.

FENOFIBRATE problem was reported by a Consumer or non-health professional from FRANCE on Sept 16, 2002. Male patient was diagnosed with dyslipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: tendon disorder. FENOFIBRATE dosage: unknown. During the same period patient was treated with GLICLAZIDE, ASPIRIN, METFORMIN HYDROCHLORIDE, DICLOFENAC. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from AUSTRALIA reported FENOFIBRATE problem on Jan 21, 2002. Male patient was diagnosed with dyslipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: parotitis. FENOFIBRATE dosage: unknown. During the same period patient was treated with GLICLAZIDE, METFORMIN HYDROCHLORIDE, MONOPLUS, FOSINOPRIL. Patient was hospitalized. Patient recovered.

FENOFIBRATE problem was reported by a Consumer or non-health professional from FRANCE on Aug 25, 2003. Female patient was diagnosed with dyslipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: tendon rupture. FENOFIBRATE dosage: unknown. During the same period patient was treated with THEOPHYLLINE, ESTRADIOL, TESTOSTERONE, FUROSEMIDE, FOSINOPRIL, ACTOS, GLUCOPHAGE, BIOGLAN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from AUSTRALIA reported FENOFIBRATE problem on May 17, 2004. Male patient was diagnosed with dyslipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: pulmonary embolism. FENOFIBRATE dosage: unknown. During the same period patient was treated with ASPIRIN, TENOXICAM, PERINDOPRIL, METFORMIN HYDROCHLORIDE, GLICLAZIDE. Patient was hospitalized. Patient recovered.

FENOFIBRATE problem was reported by a Consumer or non-health professional from on Apr 07, 2003. Male patient was diagnosed with dyslipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: diarrhoea haemorrhagic, diverticulitis. FENOFIBRATE dosage: unknown. During the same period patient was treated with ASPIRIN, PARACETAMOL, PAROXETINE HYDROCHLORIDE, DYNORM PLUS, DILTIAZEM, OMEPRAZOLE, GLYCERYL TRINITRATE, MYLANTA. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from FRANCE reported FENOFIBRATE problem on Mar 13, 2003. Female patient was diagnosed with dyslipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: pulmonary embolism, thrombosis. FENOFIBRATE dosage: unknown. During the same period patient was treated with GLIBENCLAMIDE, METFORMIN HYDROCHLORIDE, ASPIRIN, ENALAPRIL MALEATE. Patient was hospitalized. Patient died.

FENOFIBRATE problem was reported by a Consumer or non-health professional from FRANCE on Jan 20, 2003. Male patient was diagnosed with dyslipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: haematuria, micturition disorder, pain. FENOFIBRATE dosage: unknown. During the same period patient was treated with METFORMIN HYDROCHLORIDE, GLIPIZIDE. Patient recovered.

Consumer or non-health professional from AUSTRALIA reported FENOFIBRATE problem on Sept 11, 2002. Female patient was diagnosed with dyslipidaemia, glaucoma and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: pituitary tumour benign. FENOFIBRATE dosage: unknown. During the same period patient was treated with ENALAPRIL MALEATE, GLIBENCLAMIDE, METFORMIN, PARACETAMOL, MEFENAMIC ACID, BETAXOLOL HYDROCHLORIDE, AMOXICILLIN TRIHYDRATE, LONAZOLAC CALCIUM. Patient was hospitalized. Patient recovered.

FENOFIBRATE problem was reported by a Consumer or non-health professional from AUSTRALIA on Oct 02, 2002. Male patient was diagnosed with dyslipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis. FENOFIBRATE dosage: unknown. During the same period patient was treated with VERAPAMIL HYDROCHLORIDE, METFORMIN HYDROCHLORIDE, GLICLAZIDE, ASPIRIN, ROSIGLITAZONE MALEATE, PERINDOPRIL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from AUSTRALIA reported FENOFIBRATE problem on Mar 29, 2002. Female patient was diagnosed with dyslipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: azotaemia, renal failure chronic. FENOFIBRATE dosage: unknown. During the same period patient was treated with METFORMIN, INDAPAMIDE, PRAZOSIN, ESTROGENS CONJUGATED, IRBESARTAN, OMEPRAZOLE, BUDESONIDE. Patient recovered.

FENOFIBRATE problem was reported by a Consumer or non-health professional from FRANCE on Sept 12, 2005. Female patient was diagnosed with dyslipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: arthralgia, rotator cuff syndrome, tendon disorder. FENOFIBRATE dosage: unknown. During the same period patient was treated with ASPIRIN, MITOTANE, GLICLAZIDE, CALCIUM CARBONATE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from AUSTRALIA reported FENOFIBRATE problem on Apr 29, 2005. Female patient was diagnosed with dyslipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: hepatic function abnormal, hepatic steatosis. FENOFIBRATE dosage: unknown. During the same period patient was treated with RANITIDINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE. Patient recovered.

FENOFIBRATE problem was reported by a Consumer or non-health professional from FINLAND on July 23, 2002. Female patient was diagnosed with dyslipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis. FENOFIBRATE dosage: unknown. During the same period patient was treated with FLUTICASONE PROPIONATE, BISOPROLOL, ISOSORBIDE MONONITRATE, ASPIRIN, PRAVASTATIN, WARFARIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from AUSTRALIA reported FENOFIBRATE problem on Aug 27, 1999. Female patient was diagnosed with dyslipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis, pulmonary embolism. FENOFIBRATE dosage: unknown. During the same period patient was treated with CEPHALEXIN, ENALAPRIL, INDAPAMIDE, VERAPAMIL, WARFARIN. Patient was hospitalized. Patient recovered.

FENOFIBRATE problem was reported by a Consumer or non-health professional from AUSTRALIA on Oct 21, 2004. Female patient was diagnosed with dyslipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: apnoea. FENOFIBRATE dosage: unknown. During the same period patient was treated with OMEPRAZOLE, ASPIRIN, KARVEA HCT, TERBUTALINE SULPHATE, DIAZEPAM, GLICLAZIDE, ACETAMINOPHEN W. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from FRANCE reported FENOFIBRATE problem on Mar 22, 2004. Male patient was diagnosed with dyslipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: renal colic. FENOFIBRATE dosage: unknown. During the same period patient was treated with TERAZOSIN HYDROCHLORIDE, ASPIRIN, SIMVASTATIN, PANTOPRAZOLE, MIXTARD, PIOGLITAZONE. Patient was hospitalized. Patient recovered.

FENOFIBRATE problem was reported by a Consumer or non-health professional from FRANCE on Sept 25, 2003. Female patient was diagnosed with dyslipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: pulmonary fibrosis, right ventricular failure. FENOFIBRATE dosage: unknown. During the same period patient was treated with ESTROGENS CONJUGATED, DICLOFENAC, DIPYRIDAMOLE, VERAPAMIL, TEMAZEPAM, GLICLAZIDE, MIXTARD, ALENDRONATE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from AUSTRALIA reported FENOFIBRATE problem on Feb 07, 2002. Male patient was diagnosed with dyslipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: dysphagia, oesophageal spasm. FENOFIBRATE dosage: unknown. During the same period patient was treated with RANITIDINE, AMITRIPTYLINE, CISAPRIDE, IRBESARTAN, PANTOPRAZOLE, LATANOPROST. Patient recovered.

FENOFIBRATE problem was reported by a Consumer or non-health professional from AUSTRALIA on Jan 14, 2004. Male patient was diagnosed with dyslipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: tendon disorder. FENOFIBRATE dosage: unknown. During the same period patient was treated with METFORMIN HYDROCHLORIDE, ASPIRIN, TOCOPHEROL CONCENTRATE CAP, VITAMIN, PRAVASTATIN, SILDENAFIL CITRATE, RAMIPRIL, ALPRAZOLAM. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from reported FENOFIBRATE problem on Aug 21, 2003. Male patient was diagnosed with dyslipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: alveolitis fibrosing, renal failure acute, respiratory tract infection. FENOFIBRATE dosage: unknown. During the same period patient was treated with GLIBENCLAMIDE, METFORMIN HYDROCHLORIDE. Patient was hospitalized. Patient died on 06/23/2003.

FENOFIBRATE problem was reported by a Consumer or non-health professional from FINLAND on Apr 10, 2002. Male patient was diagnosed with dyslipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: cardiac failure. FENOFIBRATE dosage: unknown. During the same period patient was treated with ASPIRIN, BISOPROLOL, FUROSEMIDE, PARACETAMOL, GLIMEPIRIDE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from AUSTRALIA reported FENOFIBRATE problem on May 17, 2002. Male patient was diagnosed with dyslipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: muscular weakness, myalgia, red blood cell sedimentation rate increased. FENOFIBRATE dosage: unknown. During the same period patient was treated with QUININE SULPHATE, CELECOXIB, ROFECOXIB, ASCORBIC ACID. Patient was hospitalized. Patient recovered.

FENOFIBRATE problem was reported by a Consumer or non-health professional from FRANCE on Dec 11, 2003. Male patient was diagnosed with dyslipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: aneurysm, aortic aneurysm, aortic aneurysm rupture. FENOFIBRATE dosage: unknown. During the same period patient was treated with METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE, GLICLAZIDE, PERINDOPRIL, PARACETAMOL, AMLODIPINE BESYLATE, SIMVASTATIN. Patient died on 11/21/2003.

Consumer or non-health professional from FRANCE reported FENOFIBRATE problem on June 08, 2004. Female patient was diagnosed with dyslipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: pulmonary embolism. FENOFIBRATE dosage: unknown. During the same period patient was treated with DIVINA, ACETAMINOPHEN W, LISINOPRIL, ASPIRIN, LANSOPRAZOLE, GLIMEPIRIDE, INSULIN ISOPHANE, MAGNESIUM HYDROXIDE. Patient was hospitalized. Patient recovered.

FENOFIBRATE problem was reported by a Consumer or non-health professional from AUSTRALIA on June 11, 2002. Male patient was diagnosed with dyslipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: tendon rupture. FENOFIBRATE dosage: unknown. During the same period patient was treated with FELODIPINE, ASPIRIN, PHENERGAN, KARVEA HCT, WARFARIN, GLIBENCLAMIDE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from AUSTRALIA reported FENOFIBRATE problem on Feb 21, 2005. Male patient was diagnosed with dyslipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: bone marrow failure. FENOFIBRATE dosage: unknown. During the same period patient was treated with ASPIRIN, QUININE, IRBESARTAN, VENLAFAXINE, FOLATE, METFORMIN HYDROCHLORIDE, GLICLAZIDE, ROSIGLITAZONE MALEATE. Patient recovered.

FENOFIBRATE problem was reported by a Consumer or non-health professional from AUSTRALIA on Jan 20, 2005. Female patient was diagnosed with dyslipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: bladder cancer. FENOFIBRATE dosage: unknown. During the same period patient was treated with GLICLAZIDE, METFORMIN HYDROCHLORIDE, BRUFEN. Patient recovered.

Consumer or non-health professional from NEW ZEALAND reported FENOFIBRATE problem on Aug 16, 2001. Female patient was diagnosed with dyslipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: anaemia, confusional state, gastritis, hepatic function abnormal, pneumonia, pyrexia, sepsis, weight decreased. FENOFIBRATE dosage: unknown. During the same period patient was treated with METFORMIN, AMITRIPTYLINE, THIORIDAZINE, ALLOPURINOL. Patient was hospitalized. Patient died on 05/04/2001.

FENOFIBRATE problem was reported by a Consumer or non-health professional from FRANCE on Sept 24, 2004. Male patient was diagnosed with dyslipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: atrioventricular block. FENOFIBRATE dosage: unknown. During the same period patient was treated with DICLOFENAC, NOVOLIN, INDOMETHACIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from FRANCE reported FENOFIBRATE problem on Aug 06, 2002. Male patient was diagnosed with dyslipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, cholelithiasis, hepatic function abnormal, jaundice, musculoskeletal disorder, myalgia. FENOFIBRATE dosage: unknown. During the same period patient was treated with FELODIPINE, PERINDOPRIL, METFORMIN HYDROCHLORIDE, ATENOLOL, RANITIDINE HYDROCHLORIDE, DIPYRIDAMOLE, GLIPIZIDE. Patient was hospitalized. Patient recovered.

FENOFIBRATE problem was reported by a Consumer or non-health professional from AUSTRALIA on Nov 10, 1999. Female patient was diagnosed with dyslipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: anorectal disorder, duodenitis, dysplasia, nausea, rectal haemorrhage, rectal polyp. FENOFIBRATE dosage: unknown. During the same period patient was treated with MONOPRIL, VITAMIN, WARFARIN, NIZATIDINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from FRANCE reported FENOFIBRATE problem on Sept 07, 2004. Male patient was diagnosed with dyslipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: cholangitis, cholelithiasis, renal cyst. FENOFIBRATE dosage: unknown. During the same period patient was treated with ATENOLOL, LEVOTHYROXINE, ALLOPURINOL, METFORMIN, FELODIPINE, QUINAPRIL. Patient was hospitalized. Patient recovered.

FENOFIBRATE problem was reported by a Consumer or non-health professional from FRANCE on Jan 20, 2006. Male patient, 57 years of age, was diagnosed with type iib hyperlipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: becker's muscular dystrophy, blood creatine phosphokinase increased, mitral valve incompetence, myalgia, myopathy toxic, myositis. FENOFIBRATE dosage: unknown. During the same period patient was treated with ATORVASTATIN CALCIUM, INFLUENZA VACCINE, INFLUENZA VACCINE. Patient was hospitalized. Patient recovered.

Health Professional from AUSTRIA reported FENOFIBRATE problem on Feb 07, 2006. Male patient, 75 years of age, was diagnosed with hypertriglyceridaemia, diabetes mellitus inadequate control and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, diabetes mellitus inadequate control, liver function test abnormal, metabolic disorder, myopathy, renal impairment. FENOFIBRATE dosage: 200 MG; QD; PO. During the same period patient was treated with ROSIGLITAZONE, PHENPROCOUMON, VALSARTAN, SYMPATHOMIMETICS, METFORMIN. Patient was hospitalized. Patient recovered.

FENOFIBRATE problem was reported by a Physician from UNITED STATES on Mar 07, 2006. Male patient, 70 years of age, was diagnosed with dyslipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: proteinuria, rhabdomyolysis. FENOFIBRATE dosage: 160 MG;PO. During the same period patient was treated with SIMVASTATIN, ATENOLOL, LEVOTHYROXINE, ROSIGLITAZONE, RANITIDINE, TERAZOSIN. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported FENOFIBRATE problem on Mar 03, 2006. Female patient, 67 years of age, was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: aldolase increased, blood creatine phosphokinase mb increased, cardiac aneurysm, cardiac failure acute, chest discomfort, chest pain, congestive cardiomyopathy. FENOFIBRATE dosage: 160 MG;QD;. During the same period patient was treated with ROSUVASTATIN, HYDROCHLOROTHIAZIDE, OXAPROZIN. Patient was hospitalized. Patient recovered.

FENOFIBRATE problem was reported by a Physician from FRANCE on Mar 16, 2006. Female patient, 72 years of age, was diagnosed with hypercholesterolaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, myalgia. FENOFIBRATE dosage: unknown. During the same period patient was treated with HOMEOPATIC PREPARATION, AMLODIPINE BESYLATE. Patient recovered.

Pharmacist from UNITED STATES reported FENOFIBRATE problem on Mar 24, 2006. Male patient, weighting 184.0 lb, was diagnosed with hyperlipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: rhabdomyolysis. FENOFIBRATE dosage: unknown. During the same period patient was treated with PRAVASTATIN, ALLOPURINOL, ALPROSTADIL, ASPIRIN, ATENOLOL, BUPROPION, CARBOXYMETHYL CELLULOSE, CLOPIDOGREL. Patient recovered.

FENOFIBRATE problem was reported by a Physician from TURKEY on Mar 20, 2006. Female patient, 63 years of age, was diagnosed with hyperlipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: autoimmune thyroiditis, blood pressure abnormal, carpal tunnel syndrome, conjunctival disorder, constipation, dry skin, dysphonia, fatigue. FENOFIBRATE dosage: 200 MG; QD;. During the same period patient was treated with SIMVASTATIN, ENALAPRIL MALEATE. Patient was hospitalized. Patient recovered.

< Previous  Showing 101-150 of 194 Next >